Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
1(8%)
Results Posted
33%(1 trials)
Terminated
3(23%)

Phase Distribution

Ph not_applicable
12
92%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(3)
Terminated(3)
Other(5)

Detailed Status

unknown5
Terminated3
Completed3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (7.7%)
N/A12 (92.3%)

Trials by Status

recruiting18%
terminated323%
not_yet_recruiting18%
completed323%
unknown538%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13